Ep.99 – Unexpected Findings: Ertapenem in Surgical Prophylaxis

Episode Notes

For this episode, Dr. Libby Dodds Ashley is joined by Dr. Chris Hostler to discuss Dr. Hostler’s recent article evaluating postoperative outcomes in patients receiving ertapenem for colon surgery. This article that includes some data from our DASON sites so this is a MUST listen! The article reviewed in this episode can be found here: https://pubmed.ncbi.nlm.nih.gov/39363596/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Ep.97 – A Multicenter Retrospective Study Evaluating Intravenous to Oral Antibiotic Stepdown for Uncomplicated Streptococcal Bacteremia

Episode Notes

In this episode of the DASON Digest podcast, DASON Clinical Pharmacist Liaison Dr. Melissa Johnson reviews an article that compares the efficacy and safety of intravenous (IV) versus oral (PO) stepdown therapy for uncomplicated streptococcal bacteremia. The article can be found here: https://academic.oup.com/ofid/article/11/7/ofae361/7701251

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Waiting on a Culture: Impact of pharmacist-led microresult follow-up post-discharge

Episode Notes

In this episode, Dr. April Dyer discusses a recent article in Antimicrobial Stewardship and Hospital Epidemiology on how pharmacists can help with post-hospital discharge micro result review. The article reviewed in today's episode can be found here: https://www.cambridge.org/core/journals/antimicrobial-stewardship-and-healthcare-epidemiology/article/impact-of-pharmacistled-microbiology-result-followup-postdischarge-for-patients-undergoing-inpatient-infectious-diseases-consultation/ED155B2C10D145480228E715ABCFB000

For more information about DASON, please visit: https://dason.medicine.duke.edu/

Ep.92 – Is One Better Than the Other? Analyzing surrogates for oral cephalosporin susceptibilities

Episode Notes

In this exciting episode, Dr. Jeannette Bouchard is joined by Drs. Katie Lambert and Catessa Howard to discuss their newly published brief report in OFID that helps shine a light on a common clinical issue, is cefazolin or ceftriaxone a better surrogate for third generation oral cephalosporins.

The article reviewed in this episode can be found here: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11245689/

For more information about DASON, please visit: https://dason.medicine.duke.edu/

2020